Wednesday, 7 August 2019

Know more about Anticholinergic Drugs Market 2019| Pfizer, Allergan Plc, Astellas Pharma, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd, Sanofi

Anticholinergic Drugs Market Highlights
The Global Anticholinergic Drugs Market is projected to reach USD 7,149.90 Million by 2024 at a CAGR of 4.50% during the review period from 2019 to 2024.
. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.
The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.
Anticholinergic Drugs Market- Segment Analysis
The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, semi-synthetic compounds. The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, muscle spasms, irritable bowel syndrome. On the basis of route of administration, the market is segmented into oral, parenteral, topical. On the basis of end user, the market is segmented into hospitals and pharmacies.
 Regional Analysis
The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.
Key Findings of the Study
  • The Global Anticholinergic Drugs Market is projected to reach USD 7,149.90 Million by 2024 at a CAGR of 4.50% during the review period from 2019 to 2024.
  • Americas accounted for the largest share of the global market due to the high prevalence of CNS diseases and demand for effective therapies.
  • The overactive bladder application segment accounted for the largest market share of 4% in 2018.
Intended Audience
  • Pharmaceutical Companies
  • Research and Development Organizations
  • Academic Institutes
Anticholinergic Drugs Market Studied By Top Players
Market Research Future (MRFR) recognizes following companies as key players in the global anticholinergic drugs market that include Pfizer Inc. (US), Allergan Plc (US), Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Sanofi (France), GlaxoSmithKline Plc (UK), Boehringer Ingelheim International GmbH (Germany) and others.
 List Of Table
Table 1 List Of Assumptions 15 
Table 2 Global Anticholinergic Drugs Market, By Type 2016-2024 (Usd Million) 32 
Table 3 Global Anticholinergic Drugs Market For Synthetic Compounds, By Region, 2016–2024 (Usd Million) 32 
Table 4 Global Anticholinergic Drugs Market For Natural, By Region, 2016–2024 (Usd Million) 33 
Table 5 Global Anticholinergic Drugs Market For Semi-Synthetic Compounds, By Region, 2016–2024 (Usd Million) 33
Table 6 Global Anticholinergic Drugs Market, By Application 2016-2024 (Usd Million) 36 
Table 7 Global Anticholinergic Drugs Market For Overactive Bladder, By Region, 2016–2024 (Usd Million) 36 
Table 8 Global Anticholinergic Drugs Market For Parkinson’s Disease, By Region, 2016–2024 (Usd Million) 37 
Table 9 Global Anticholinergic Drugs Market For Chronic Obstructive Pulmonary Disease (Copd), By Region, 
2016–2024 (Usd Million) 37 
Table 10 Global Anticholinergic Drugs Market For Muscle Spasms, By Region, 2016–2024 (Usd Million) 38 

Hottest Trending Reports




 About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Healthcare Consulting Services Market to Register a Steady Expansion at CAGR 10.4% by 2024

Market Insight
The healthcare consulting services market is getting positive vibes across the globe due to its smooth functioning of diverse activities in less amount of time. Market Research Future has published a report on global healthcare consulting services market, which states that the market is anticipated to grow positively at a CAGR of 10.4% during the forecast period of 2019 to 2024.

Healthcare consultant or healthcare consulting services is considered to be a business that is associated with providing services that are used by healthcare companies, hospitals, clinics, to instrument a new strategy for proper management of activities such as accounting, marketing, finance, insurance in the healthcare industry. These are essential factors that are contributing to the growth of the market significantly.

Key players for Global Healthcare Consulting Services Market

  • Accenture Consulting (US)
  • McKinsey and Company (US)
  • Cognizant (US)
  •  Deloitte Consulting (US)
  •  Ernst and Young (UK)
  •  Bain and Company (US)
  •  Deloitte Touche Tohmatsu Limited (US)
  •  Huron Consulting (US)
  •  KPMG (Switzerland)
  •  PWC (UK)
  •  The Boston Consulting Group (US)

Market Drivers & Trends
The global healthcare consulting services market is on the verge of growing due to an increase in the demand for healthcare consulting services across the globe. The surge in demand is causing for increasing globalization, rising demand for healthcare products, and the addition of a new few features in the healthcare industry.
Apart from this, the growing competition in the healthcare sector has also fortified significant companies to focus on the development of their business strategies. The development of the product, it's manufacturing, designing, and marketing also depends on the growth of the market. Therefore, these factors are claiming to be advantageous for the global healthcare consulting services market for tremendous growth over the assessment period.
Other prominent factors such as growth in the global aging population, the rising worth of valuable care as well as technical developments in the healthcare industry are driving the growth of the market exponentially.
However, on the flip side, the factors such as the availability of similar technology and low product differentiation may pose as a hamper to the global healthcare consulting services market growth. Besides, the problem of data confidentiality is also expected to be a hamper to the growth of the market to an extent during the forecast period.
Intended Audience
  • Biotechnological Institutes Hospitals and Clinics
  • Ambulatory Care Centers & Home Care Settings
  • Pharmaceutical & Biotech Companies
  • Government Healthcare Institutes
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers

Market Segmentation
The segmentation of the global healthcare consulting services market has been done based on the type of services, component, application, and end-user.
By type of services: IT consulting, digital consulting, financial consulting, operations consulting, and strategy consulting is the segments.
By component: Services, software, and hardware are the segments.
By application: operations management, financial, population health, and clinical are the segments. Operations management is further sub-segmented into demand forecasting, workforce planning and scheduling, inpatient scheduling, and outpatient scheduling. Then based on population health, the segments under it are population risk management, patient engagement, population therapy management, and others.
While by finance, the market is sub-segmented into revenue cycle management, fraud detection, an based on clinical the market is sub-segmented into quality benchmarking, patient care enhancement, and clinical outcome analysis and management.
By the end-user, hospitals and clinics, life science companies, and government bodies are the segments.

Regional Outlook
The Americas dominate the global healthcare consulting services market owing to the increase in healthcare infrastructure, growing awareness about the patient safety methods and increasing competition in healthcare companies opts for healthcare consultants for various solution and strategies which increases the demand for healthcare consulting services within the region.
Europe is second in the global healthcare consulting services market owing to increasing adaption of IT services in healthcare and increasing awareness about the healthcare consulting services is promoting the market across the globe.
The Asia-Pacific region is the fastest growing market owing to the increasing patient population, rising demand for various healthcare facilities for better treatment and increasing healthcare expenditure drives the market with the region. The Middle East & Africa has the least share in the global healthcare consulting services market owing to the presence of poor economies and low per capita income, especially in the African region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Monday, 5 August 2019

Substance Abuse Treatment Market Will Reflect Significant Growth Prospects of 11.6% CAGR during 2017-2023

Market Highlights
Global substance abuse treatment market is projected to witness a strong growth over the next several years. As per the latest report published by Market Research Future (MRFR), the global substance abuse treatment market will surge at 11.6% CAGR during the forecast period (2018-2023). Today, substance abuse is endemic all around the wold with teenagers being the main victims.
Demand for substance abuse treatment is fuelled by rising number drug addiction cases, improvement in overall treatment approach, rising patient awareness regarding the benefits of substance abuse treatment and growing government support. Nonetheless, treatment compliance remains poor developing countries. In addition, reluctance or negligence among individuals is viewed as major challenge. 
Key Players
Some of the key players in the global substance abuse treatment market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., Purdue Pharma LP, Allergan, Mylan Laboratories, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceuticals, Forest Laboratories, Inc., Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharmaceuticals, and others.
Substance Abuse Treatment Market Regional Insight
The primary markets for substance abuse treatment are Europe, the Americas, Middle East & African and Asia Pacific.
In 2017, the Americas was identified as the leading substance abuse treatment market. The market’s prominence is the result of the presence of esteemed players, coupled with the mounting awareness about substance abuse treatment. In the past few years, several private, as well as government organizations, have been launching campaigns and seminars with the aim of spreading awareness about substance abuse. This works wonders for the regional market. Citing a reference, in February 2017, the Ad Council, along with Viacom, launched the LISTEN campaign which spoke about America’s substance abuse crisis.
In 2017, it was estimated that Europe stood second in the global substance abuse treatment market. The regional market benefits from the rise in research and development investments as well as increasing number of initiatives by the government to treat substance abuse patients.
With the fastest growth rate in the market in 2017, Asia Pacific is soaring high on the back of growing incidences of tobacco addiction coupled with the surge in technological advancements. The Frontiers in Psychiatry journal reveals that China faces massive public health challenge due to progressing tobacco smoking. It is reported that the number of deaths by cigarette smoking could reach the valuation of 2 million by 2030 and finally reach 3 million by 2050.
Lastly, Middle East and Africa accounted for the smallest share in the global substance abuse treatment market. The low per capita income, particularly in Africa, could be the main reason for the lackluster market performance.
Segmentation
The Global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.
Global Substance Abuse Treatment Market, by Abuse Type
  • Alcohol Dependence
  • Tobacco/Nicotine Addiction
  • Drug Abuse
  • Others
Global Substance Abuse Treatment Market, by Treatment Type
  • Alcohol Addiction Treatment
    • Disulfiram
    • Acamprosate
    • Naltrexone
  • Tobacco/Nicotine Addiction Treatment
    • Nicotine Replacement Treatment
      • Nicotine Patch
      • Nicotine Gum
      • Nicotine Lozenge
      • Nicotine Spray
      • Nicotine Inhaler
    • Non-Nicotine Medication
      • Bupropion
      • Varenicline
  • Drug Abuse Treatment
    • Methadone
    • Buprenorphine
    • Naltrexone
Global Substance Abuse Treatment Market, by End User
  • Outpatient Treatment Centers
  • Residential Treatment Centers
  • Inpatient Treatment Centers
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Global Prostate Cancer Market Overview, Growth Analysis and Top 10 Players By 2023

Global Prostate cancer Treatment Market Research Report - Forecast till 2027”  – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027.
Global Prostate cancer Market – Overview
The global Prostate Cancer Market is showing the steady growth; mainly owing to increase in patient population. According to report published by Centers for Disease Control and Prevention, in 2014, there were around 172,258 men in the United States, who diagnosed with prostate cancer and around 28,343 men died from prostate cancer. These rising number of prostate cancer create an opportunity for the player to introduce innovative treatment option.
Companies are continuously invent new treatment to capture the global market. Thus players invest more in research and development activities. In this regards, Bayer Pharma AG announced that they have many drugs for the treatment of prostate cancer in there pipeline such as Radium-223 dichloride and BAY 1841788 (ODM-201, AR antagonist).
Progenics Pharmaceuticals, Inc., 2015, acquired Exini Diagnostics AB in order to support its imaging and therapeutic agents with sophisticated analytical tools and other technologies to help patients and physicians understand, target and treat prostate cancer. These companies are more investing in research and development program to provide the best treatment option, which help them to keep ahead with their competitor.
These acquisitions help companies to provide better treatment opportunity in the market and hence improve the quality of life for the people around the world. Additionally it help market players in translating breakthrough science into innovative treatment to help people with prostate cancer worldwide.
Key Players:      
OncoGenex Pharmaceuticals Inc. (U.S.), Bayer Pharma AG (Berlin), Progenics Pharmaceuticals, Inc. (U.S.), Tolmar Inc. (U.S.), OncBioMune Pharmaceuticals Inc. (U.S.), Endo Pharmaceuticals Inc. (U.S.), Tokai Pharmaceuticals, Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of prostate cancer, globally.
Prostate cancer is the most common non skin cancer, which affects the gland that produces some of the fluid in semen and plays an important role in controlling urine of men. This is one of the most common type of cancer in men, which grow slowly and is initially confined to prostate gland, where it may not cause serious harm. According to estimate done by the American Cancer Society, in 2017, there will be around 161,360 new diagnoses of prostate cancer, and that around 26,730 fatalities will occur because of it.
 Intended Audience:
  • Companies related to Prostate cancer
  • Government research Laboratories
  • Research and Development (R&D) Companies
  • Independent Research Laboratories
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
Global Prostate cancer Market   - Regional Analysis
According to Prostate cancer Foundation, it is the most common type of cancer in United States. The Older you are more chance of getting diagnosed with prostate cancer. 1 in 8 men get diagnosed with this type of cancer at some points of age.
According to American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will get diagnosed and around 26,730 death occurs owing to prostate cancer in United States. Report suggest more than 2.9 million men get diagnosed with prostate cancer at some point are still alive today. The market of prostate cancer is much higher in the Americas region attribute to high rate of obesity population. The government have more focus towards research and development for introducing the best treatment for their population.
Europe is also consider huge market for prostate cancer market players, owing to present of huge population affected with disease. Company in this region have well developed treatment option, whereas developing countries are more focus to obtain well developed treatment in order to provide best treatment to their citizen. Thus, players are involve in exporting the advanced treatment and maximizing the profit by capturing market share of Asia Pacific. Government are more focusing to educate their public in order to minimize the patient’s population by educating them about the side effect of unhealthy diet, obesity etc.
Asia Pacific region are considering the growing market, owing to presence of huge population suffering with prostate cancer. Whereas country like India and china are considering fastest growing region due to the high rate of obesity population which leads the incidence of prostate cancer, additionally they are open to adopt new technology, and best treatment option from developed countries in order to improve the quality of life for their citizen. Whereas the Middle East and Africa have low market due to his incapability of investment, Moreover developing countries are still focusing on new drugs for the treatment of prostate cancer, this gap between the developed and developing countries will present significant growth opportunity for the prostate cancer treatment market players in the coming years.
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
 ...

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for Asia Pacific, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Research Details Global Artificial Neural Network Industry 2016 Market Size, Share ,Growth ,Trends and Forecast 2023

Market Analysis
The global Artificial Neural Network (ANN) Market is expected to grow exponentially at an appealing CAGR over the assessment period (2018-2023). Artificial neural network also called neural network is different from the remaining machine learning algorithms which organize data or crunch numbers. This is basically a computational model that resembles the structure and function of the neuron system present in the human brain. This software can be utilized for clinical diagnosis of different diseases, drug development, medical research and interpretation of the clinical imaging techniques.
Key Players
Key players profiled in the artificial neural network market include Oracle Corporation, IBM Corporation, Microsoft Corporation, Intel Corporation, Qualcomm Technologies, Inc., Neuralware, Google Inc., Alyuda Research, LLC., NeuroDimension, Inc., SAP SE, Ward Systems Group, Inc., Afiniti, SwiftKey, Neural Technologies Limited, and Starmind International AG.
There are various factors that is driving the growth of the artificial neural network market according to MRFR (Market Research Future) Report. These include growth in the Information Technology expenditure in the emerging nations, advancements in technology for workflow optimization, increasing demand for cloud-based solutions, need for analytics tools and spatial data, rise in market for prediction solutions, growing application areas for deep neural networks, emergence of AI (artificial intelligence), rising healthcare investment by the government especially in developed regions, increasing existence of various chronic diseases and increasing use of artificial neural network in healthcare domain. On the contrary, factors such as reluctance amid healthcare experts in adopting AI based technologies and slow digitization across the emerging economies are likely to hamper the growth of the artificial neural network market.


Market Segmentation
As per MRFR report, the global artificial neural network market is segmented on the basis of type, component and application.
Based on type, it is segmented into feedforward artificial neural network, feedback artificial neural network and others. Of these, the feedforward network is anticipated to have the maximum share in the artificial neural network market.
Based on component, the artificial neural network market is segmented into platform, services and software.
Based on application, it is segmented into drug development, interpretation, bioelectric signal analysis, image analysis & interpretation, clinical diagnosis & prognostics and others.
Regional Analysis
Based on region, the artificial neural network market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will have an upper hand in the artificial neural network market due to increasing use of advanced technology in the healthcare domain, existence of a huge number of enterprises especially in the creation of neural network technologies and the presence of a well-developed healthcare sector. The artificial neural network market in the Middle East and Africa will have a minimal share in the market but nonetheless this region is anticipated in having a prospective growth opportunity for artificial neural network market over the assessment period. Here the factors that can be attributed for the growth of the market include rising investments in the healthcare domain and technological implementations. In Europe the artificial neural network market grabs the second largest share owing to the rising adoption of AI amid healthcare providers, increasing prevalence of chronic diseases and increasing healthcare expenditure. On the other hand, the artificial neural network market in the APAC region is anticipated in exhibiting the fastest growth over the assessment period due to a couple of factors such as increasing need to control the growing healthcare costs and the accelerated economic growth of some countries in this region. In fact, these factors are also accountable for the growing trend for digitization of patient records amid the region’s healthcare organizations.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...

Latest Trending Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Kidney Dialysis Equipment Market 2017-2023 – Worldwide Trends, Statistics, Size, Share, Regional Analysis by Key Players, Application & Products

The global kidney dialysis equipment market is touted to accumulate USD 16.5 billion at a stupendous 5.7% CAGR during the assessment period (2018-2023). CKD or chronic kidney disease is a chronic condition which seriously impacts a patient’s quality of life. Kidney dialysis is the most preferred treatment for severe conditions where both the kidneys of a person is damaged but this treatment is also occasionally used for treating patients with a single damaged kidney. Every day, the kidney of a healthy person filters about 150 quarts of blood. Should an individual’s kidney fail to function efficiently automatically the waste will get collected in the blood resulting in coma and even death. Here dialysis will act as the savior. It will stop the toxin and waste products formation in the blood. It is an artificial kidney that is used for filtering the blood of the patient during kidney failure, kidney dysfunction and kidney damage and for removing surplus impurities from kidneys.
Kidney Dialysis Equipment Market- Segmentation
The worldwide kidney dialysis equipment market has been segmented based on apparatus type, end-user, and type.
Based on apparatus type, the kidney dialysis equipment market has been segmented into peritoneal dialysis device, consumables, hemodialysis apparatus, and continuous renal replacement therapy systems. The hemodialysis equipment has been sub-segmented into tunneled hemodialysis catheters, vascular access devices, bloodline system, solutions, filters, concentrates, dialyzers and hemodialysis machine. The peritoneal dialysis equipment has been sub-segmented into dialyzers, filters, concentrates, solutions, and automated peritoneal dialysis devices. Of these, the hemodialysis equipment market is likely to hold the major market share.
Based on end-user, the kidney dialysis equipment market has been segmented into home care, ambulatory services, hospitals, and in-center dialysis settings.
Based on type, the kidney dialysis equipment market has been segmented into peritoneal dialysis, hemodialysis, and Continuous Renal Replacement Therapy (CRRT). Hemodialysis has been sub-segmented into short daily hemodialysis, conventional hemodialysis, and nocturnal hemodialysis. The Peritoneal dialysis has been sub-segmented into Continuous Cycling Peritoneal Dialysis (CCPD), Intermittent Peritoneal Dialysis (IPD), Tidal Peritoneal Dialysis, and Continuous Ambulatory Peritoneal Dialysis (CAPD).
Regional Analysis
Based on region, the kidney dialysis equipment market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America is likely to command the market owing to the rising incidence of kidney failure, rising cases of diabetes and hypertension and higher reusable income amid people. Europe will have the second biggest share due to advanced medical compensation and progressive organizations. The kidney dialysis equipment market in APAC possess an unprecedented market potential owing to increasing incidences of kidney failure, increase in disposable income, presence of large geriatric population and low rates of organ transplantation. The kidney dialysis equipment market in the Middle East and Africa will have minimal share owing to low per capita income and stringent government policies.
Key Players
Leading players profiled in the kidney dialysis equipment market include Hemoclean CO., LTD, Teleflex Incorporated, Rockwell Medical, Terumo Corporation, Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation), Mar Cor Purification, Inc. (A Cantel Medical Company), Nikkiso Co., Ltd., Nxstage Medical, Inc., Nipro Corporation, Diaverum Deutschland GmbH, B. Braun Melsungen AG, Baxter International Inc., Davita Healthcare Partners Inc and Fresenius Medical Care AG & Co. Ka.
Feb 2019- Leading dialysis service provider, US Renal Care, Inc will be acquired by Investor Group with an aim to improve the quality of life for those having chronic renal disease.
April 2018- MRCS (Malaysian Red Crescent Society) and KDC (Kidney Dialysis Centre) off late has received accolades for their success to help countless patients in the last 22 years.
Intended Audience
  • Dialysis equipment and consumables manufacturing companies
  • Dialysis services providers
  • Nephrologists
  • Dialysis nurses
  • Critical care nurses
  • Distributors, suppliers, and commercial service providers
  • Hospitals, clinics, and dialysis centers
  • Research laboratories and academic institutes
  • Clinical Research Organizations (CROs)

Trending Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: ,

Friday, 2 August 2019

Cancer Biological Therapy Market Share, Growth Factors, Historical Analysis, Sales Revenue, Development Status, Emerging Opportunities, Competitive Landscape and Regional Forecast to 2023

Market Highlights
Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors.


Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Most of the biological therapies use bacteria or vaccines to mimic the body’s immune system to act against cancer developing cells. These various types of biological therapies, which are most of the times stated to biological response modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.
Segmentation:
The global Cancer Biological Therapy market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors. Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.
Regional Analysis:
Global cancer biological therapy market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa. North America is expected to commands the largest market share due to advanced technologies are continuously on rise in these countries. Europe accounts for the second largest market, where as Asia Pacific with lots of opportunity and continuously growing economies, is expected to be the fastest growing segment. Majorly due to recent developments in healthcare and improving economies. Middle East and Africa with less economic developments and extremely low income accounts for least market share in 2016 but is expected to grow with better cancer treatment in the countries.
Global Cancer Biological Therapy Market Players:
Key players profiled in the report are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, F. Hoffmann-La Roche AG, EnGeneIC Ltd, Merck & Co., Inc., Novartis,Pfizer Inc. and others.


Latest Trending Reports 

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)